Who makes Polydatin Injectable?

Polydatin Injectable is developed by Neptunus Pharmaceuticals Inc..

What development phase is Polydatin Injectable in?

Polydatin Injectable is in Phase 2.

Last reviewed 2026-04-19 · How we verify

Polydatin Injectable

Neptunus Pharmaceuticals Inc. · Phase 2 active Small molecule

At a glance

Generic name	Polydatin Injectable
Also known as	HW6
Sponsor	Neptunus Pharmaceuticals Inc.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Polydatin Injectable (HW6) for Shock Treatment (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Polydatin Injectable CI brief — competitive landscape report
Polydatin Injectable updates RSS · CI watch RSS
Neptunus Pharmaceuticals Inc. portfolio CI